SP 500 Climbs on Tech Strength Energy Staples Drag Mizuho Maintains Outperform Rating on ON Semiconductor Raises Price Target on AI Tailwinds Applied Digital Releases Fiscal Third Quarter 2026 Results Focus on AI Infrastructure Growth Genpact CEO Indicates Artificial Intelligence Could Reduce IT Workload and Reshape Industry Employment SpaceX OpenAI and Anthropic Valued Above 14 Trillion in Polymarket Trading Speculation FirstTime Buyer Challenges At Crisis Level Since 2008 Warns Barratt Redrow CEO APD Q1 2026 Earnings EPS Beats Estimates but Stock Slips CF Industries Q1 2026 Earnings EPS Beats Expectations Amidst Stable Operations FCRX Q1 2026 Earnings Narrow Miss on EPS Stable Note Performance CREX Q1 2026 Earnings EPS Falls Sharply Below Estimates Despite Positive Stock Reaction RRX Q1 2026 Earnings EPS Surpasses Estimates Shares Edge Higher CMPS Q1 2026 Earnings Narrower Loss Drives Positive Investor Sentiment Oxford Lane Capital Notes OXLCL Edge Higher at 2433 as Income Investors Monitor Key Levels Vontier Corporation VNT Gains 246 as Industrial Sector Finds Footing Plains GP Holdings PAGP Edges Lower Amid Light Trading Kymera Therapeutics KYMR Retreats 148 as Stock Tests Key Support Level Westamerica Bancorporation WABC Posts Modest Decline Holds Above Key Support DeepSeek AI Model Garners Silicon Valley Praise Highlights Chinas Chip Workaround Capabilities SKYX Q1 2026 Earnings EPS Falls Short of Estimates Amid Ongoing Development Credit Suisse High Yield Credit Fund DHY Edges Higher as IncomeFocused Investors Seek Yield FWDI Q1 2026 Earnings EPS Surges Past Estimates with 004 Profit Stock Declines WHLRD Q2 2024 Earnings Preferred Dividend Coverage Remains Robust Amid Limited Market Visibility BUSEP Q1 2026 Earnings EPS Exceeds Estimates by 1316 Almonty Industries Q1 2026 Earnings EPS Misses Estimates as Loss Widens Shares Decline REX Q3 2001 Earnings EPS Beats Estimates by 23 as Company Delivers Strong Quarter Energy Transfer LP Q1 2026 Earnings EPS Misses Estimates Despite Slight Stock Uptick PALI Q1 2026 Earnings WiderthanExpected Loss Highlights PreRevenue Biotech Challenges